Denne siden er tilgjengelig på flere språk
Select Language

All Bell ceremonies

  • Arctic Bioscience tatt opp til handel

     |  Oslo

    17212622db21957-4bdb-4343-b819-78d8de9e47db

    Arctic Bioscience tatt opp til handel

    Arctic Bioscience tatt opp til handel på Euronext Growth Oslo 22. februar 2021.

    Arctic Bioscience tatt opp til handel
    Oslo
  • CM.com – 1-year Listed

     |  Amsterdam

    1721218bb009eac-0160-4a32-a239-0bd4ca944d3e

    CM.com – 1-year Listed

    CM.com is listed on Euronext Amsterdam for 1 year. To celebrate this special moment, Gilbert Gooijers, COO of CM.com, sounded the gong this morning. He was accompanied by amongst others René van Vlerken, Head of Listing of Euronext Amsterdam. CM.com listed successfully on the Amsterdam Stock Exchange last year by a fusion with the Special Purpose Acquisition (SPAC) Dutch Star Companies One. It was the first SPAC-listing on Euronext Amsterdam.

    CM.com – 1-year Listed CM.com
    Amsterdam
  • Skandia GreenPower tatt opp til handel

     |  Oslo

    1721217c5836740-9d59-4ced-a315-15570391da3f

    Skandia GreenPower tatt opp til handel

    Skandia GreenPower tatt opp til handel på Euronext Growth Oslo 22. februar 2021.

    Skandia GreenPower tatt opp til handel
    Oslo
  • Otovo tatt opp til handel

     |  Oslo

    1721213abb06add-290c-4b1c-afc3-d1fd5051ebf1

    Otovo tatt opp til handel

    Otovo tatt opp til handel på Euronext Growth Oslo 19. februar 2021.

    Otovo tatt opp til handel
    Oslo
  • Arctic Fish tatt opp til handel

     |  Oslo

    1721212b3798b74-b425-476f-81e7-5eb572e1344d

    Arctic Fish tatt opp til handel

    Arctic Fish tatt opp til handel på Euronext Growth Oslo 19. februar 2021.

    Arctic Fish tatt opp til handel
    Oslo
  • Envipco tatt opp til handel

     |  Oslo

    1721204d4fad112-7a88-4567-a529-4920670fd8e5

    Envipco tatt opp til handel

    Envipco tatt opp til handel på Euronext Growth Oslo 18. februar 2021.

    Envipco tatt opp til handel
    Oslo
  • Sonans tatt opp til handel

     |  Oslo

    172119452a4c293-e1c4-42f2-a50b-992d93cf0a27

    Sonans tatt opp til handel

    Sonans tatt opp til handel på Euronext Growth Oslo 17. februar 2021.

    Sonans tatt opp til handel
    Oslo
  • Technip Energies lists on Euronext Paris

     |  Paris

    1721189b326e721-3f3d-4d89-b2ed-d3a2c84051d5

    Technip Energies lists on Euronext Paris

    Arnaud Pieton , Chief Executive Officer of Technip Energies , opens the trading day in Paris.

    Created from the spin-off from TechnipFMC plc group in 2021, Technip Energies N.V. is an Engineering and Technology company specialized in providing projects, technologies, products and services on energy infrastructure both onshore and offshore (LNG, downstream, sustainable chemistry, hydrogen, CO2 management and marine infrastructure).

    Technip Energies lists on Euronext Paris
    Paris
  • Pryme tatt opp til handel

     |  Oslo

    17211860a36f2b0-4612-416a-a15e-7ec1d66e3c54

    Pryme tatt opp til handel

    Pryme tatt opp til handel på Euronext Growth Oslo 16. februar 2021.

    Pryme tatt opp til handel
    Oslo
  • Huddly tatt opp til handel

     |  Oslo

    17211859da27dd2-8a26-41ab-ad31-31beb57ffa44

    Huddly tatt opp til handel

    Huddly tatt opp til handel på Euronext Growth Oslo 16. februar 2021.

    Huddly tatt opp til handel
    Oslo
  • Rize ETF – ETFs Listings

     |  Amsterdam

    17211846a60565d-72b6-4a27-b1a0-e3c7786e2aeb

    Rize ETF – ETFs Listings

    Rize ETF celebrates today the listing of three ETF’s on Euronext. Jason Kennard, co-founder of Rize ETF, sounded the gong for this cause from safe distance. He was virtually joined by amongst others Thomas Weber, ETFs Business Development Manager at Euronext. The listed ETF’s are Cybersecurity, Edtech en Sustainable food.

    Rize ETF – ETFs Listings Rize ETF – ETFs Listings
    Amsterdam
  • 172117958e26566-938f-4fe0-b01a-4dcb55e2135a

    ESG Core Investments – SPAC Listing and first day of trading

    Hans Slootweg, Managing Director of ESG Core Investments, was welcomed by Simone Huis in ‘t Veld, CEO Euronext Amsterdam. Van Roij sounded the gong on the occasion of the listing of ESG Core Investments, a Special Purpose Acquisition Company (SPAC) with a strong focus on Environment, Social and Governance (ESG). It is the first SPAC-listing on Euronext this year.

    ESG Core Investments – SPAC Listing and first day of trading SPAC-listing ESG Core Investments
    Amsterdam
  • Beaconsmind lists on Euronext Access+ Paris

     |  Paris

    17211767f0031f7-1e9c-461e-9d4c-faf7dc8f7cf3

    Beaconsmind lists on Euronext Access+ Paris

    Max Weiland , CEO and Founder, of Beaconsmind , open the trading day in Paris.

    Beaconsmind AG specializes in the development of location-based marketing software solutions for retailers. The group allows retailers to carry out marketing campaigns to increase customer loyalty, revenue and sales at the point of sale and in online.

    Beaconsmind lists on Euronext Access+ Paris
    Paris
  • Medesis Pharma lists on Euronext Growth Paris

     |  Paris

    17211757c955456-40eb-4b72-b703-6cf3dea0ff06

    Medesis Pharma lists on Euronext Growth Paris

    Jean-Claude Maurel , CEO and Founder of Medesis Pharma, opens the trading day in Paris.

    Medesis Pharma S.A. is specialized in the research and development, based on a breakthrough technology (AONYS®) for the delivery of therapeutic molecules, of drugs to treat diseases for which there is no effective treatment.

    The company's portfolio includes two candidates in the fields of neurodegenerative diseases (Alzheimer's disease and Huntington's disease), two candidates for antiviral treatments to respond to the health emergency towards the treatment of COVID-19 at different stages (one for hospitalized patients in acute respiratory distress, and another for early treatment in urban medicine), and 2 candidates to treat contaminated populations after a civil or military nuclear accident (Plutonium decorporation and cesium decorporation).

    Medesis Pharma lists on Euronext Growth Paris
    Paris
  • UBS Asset Management

     |  Amsterdam

    1721171e01215ac-2613-45ac-9343-4eba8092f65a

    UBS Asset Management – 20 years ETFs

    UBS Asset Management celebrated today that they have been offering ETFs for twenty years. Marcel Danen, Executive Director of UBS, sounded the gong from a safe distance, in the presence of Brieuc Louchard, among others, who is responsible for ETFs within Euronext. Ten years ago, UBS launched its first sustainable ETF. Since five years several ETFs have been listed on the Amsterdam stock exchange.

    UBS Asset Management UBS - 20 years ETF
    Amsterdam
  • Hydrogen Refueling Solutions

     |  Paris

    1721168e6f2aa11-7c06-43e0-8e73-bfcfe11319ac

    Hydrogen Refueling Solutions lists on Euronext Growth Paris

    Hassen Rachedi , CEO and Founder, Philippe Bottu, General Manager, and Olivier Dhez, Business Development & Marketing Director of Hydrogen Refueling Solutions , open the trading day in Paris.

    Hydrogen Refueling Solutions is specialized in the mass production of turnkey hydrogen refueling stations with large capacities (100 kg to 1 ton) for heavy vehicles (transport, buses, garbage trucks, etc.) and passenger vehicles.

    At the end of 2020, the group has a production site located in France.

    Hydrogen Refueling Solutions HRS
    Paris
  • Cambi tatt opp til handel

     |  Oslo

    1721166c236457f-5af3-4b48-8ac2-6cb07813c16a

    Cambi tatt opp til handel

    Cambi tatt opp til handel på Euronext Growth Oslo 9. februar 2021.

    Cambi tatt opp til handel
    Oslo
  • Pherecydes Pharma lists on Euronext Growth Paris

     |  Paris

    172115949f396c4-4243-44b5-a6bb-c3217c8b6b65

    Pherecydes Pharma lists on Euronext Growth Paris

    Guy-Charles Fanneau de La Horie, CEO of Pherecydes Pharma, opens the trading day in Paris.

    Pherecydes Pharma is specialized in the research and development of anti-infective therapies based on bacteriophages. Phagotherapy is an innovative approach to treat bacterial infections, including antibiotic-resistant infections, using phages, natural predators of bacteria that have no effect on eukaryotic cells, including human cells.

    Pherecydes Pharma lists on Euronext Growth Paris Pherecydes Pharma lists on Euronext Growth Paris
    Paris